Ohutusmuutused ravimiteabes september 2026
Safety Classified by Officially
Ohutusmuudatustega täpsustatakse muu hulgas ravimite hoiatusi, kõrvaltoimeid, kasutuspiiranguid ja koostoimeid.
Septembri ohutusmuudatused puudutavad järgmisi toimeaineid: aflibertsept, dimenhüdrinaat, enfortumabvedotiin, fedratiniib, ibrutiniib, koliinsalitsülaat, lamivudiin, leflunomiid, okrelizumab, oksatsilliin, osimertiniib, ribotsikliib, ritletsitiniib, sakituzumabgovitekaan, somatogroon, sugemalimab, trastuzumabderukstekaan (Enhertu) ja tsisplatiin.
Uuendatud ravimiteave on kättesaadav rubriigis Ohutusmuutused ravimiteabes.
This is an extract. The publication continues at the source.
Source: State Agency of Medicines (Ravimiamet).
Read the original at the source: https://ravimiamet.ee/uudised/ohutusmuutused-ravimiteabes-september-2026
Officially imported this from State Agency of Medicines (Ravimiamet)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- State Agency of Medicines (Ravimiamet) — imported from official source
- Official source
- https://www.ravimiamet.ee/rss-feeds/rss.xml RSS
- Imported
- October 07, 2026 07:31
- Versions
- 1 recorded
- Identity
-
3708 at https://www.ravimiamet.ee/